- Moderna to issue $2B in convertible senior notes due 2032
- Option for additional $300M in notes
Moderna is raising $2B via convertible senior notes due 2032, with an option for an extra $300M. The FDA also approved its updated 2026-2027 COVID-19 vaccines, including the new MnExSpike formula.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.